Literature DB >> 23086510

Remission of primary cutaneous anaplastic large cell lymphoma after a brief course of brentuximab vedotin.

Amrita Desai, Gladys H Telang, Adam J Olszewski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23086510     DOI： 10.1007/s00277-012-1610-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  3 in total

1.  Periocular cutaneous anaplastic large cell lymphoma clearance with brentuximab vedotin.

Authors:  Benjamin H Kaffenberger; Francisca Kartono Winardi; Julie Frederickson; Pierluigi Porcu; Henry K Wong
Journal:  J Clin Aesthet Dermatol       Date:  2013-08

Review 2.  Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment.

Authors:  Xin-Rui Zhang; Pham-Ngoc Chien; Sun-Young Nam; Chan-Yeong Heo
Journal:  Cancers (Basel)       Date:  2022-03-24       Impact factor: 6.639

3.  Improvement of Cutaneous Anaplastic Large Cell Lymphoma by Brentuximab Vedotin Monotherapy.

Authors:  Takashi Onaka; Tomoya Kitagawa; Chika Kawakami; Akihito Yonezawa
Journal:  Turk J Haematol       Date:  2018-02-02       Impact factor: 1.831
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.